AstraZeneca fails to meet target endpoints in Phase II bladder cancer trial Medical Dialogues Bureau10 March 2020 9:30 AM ISTUSA: The Phase III DANUBE trial for Imfinzi (durvalumab) and Imfinzi plus tremelimumab in unresectable, Stage IV (metastatic) bladder cancer did not...
Two Common Health Risks Early Preparation Can Save You From Ruby Khatun Khatun10 March 2018 3:43 PM ISTAs you age, the risks of health problems (including diabetes, cancer, cardiovascular and lung disease) increase and can prevent you from enjoying your...
Merck KGaA, Pfizer's immunotherapy fails in gastric cancer trial Ruby Khatun Khatun1 Dec 2017 9:30 AM ISTFRANKFURT: Germany's Merck KGaA has suffered a setback in the development of key cancer immunotherapy Bavencio, it has failed in a trial to prolong...